Exploiting TLK1 and Cisplatin Synergy for Synthetic Lethality in Androgen-Insensitive Prostate Cancer

ABSTRACT:

SUBMITTER: Bhoir S 

PROVIDER: S-EPMC10669050 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature